Literature DB >> 11316037

Prevalence of allergic bronchopulmonary aspergillosis in patients with bronchial asthma.

R Kumar1, S N Gaur.   

Abstract

Two Hundred patients with bronchial asthma were studied to identify the prevalence of allergic bronchopulmonary aspergillosis (ABPA). The patients selected required intermittent short courses of steroids and their mean duration of illness was 12 years. Absolute eosinophil count was > 500/mm3 in 53% of the cases. Chest X-rays showed small homogenous shadows with patchy infiltrations in 25% and fluctuating pneumonic shadows in 14% of the cases. Raised specific IgG and positive serum precipitin against Aspergillus fumigatus (AF) were present in 24% and 13%, respectively. Cases with radiological and immunological suspicion were further investigated for ABPA. Skin tests for Type-I and Type-III reactivity were positive with AF extract in 87% (n = 47) and 36% (n = 47) of the cases. A thorax CT of 31 patients showed central bronchiectasis in 24 cases, labeling these patients as ABPA-CB (ABPA with central bronchiectasis) and an other 7 as ABPA-S (serological positive). CT was not done in one case who, because of other positive findings, was also labeled as ABPA-S. Thus, these 32 asthmatics were found to have ABPA. Among them, there was raised specific IgG (100%) and raised specifc IgE against AF (100%), positive skin test for Type-I and Type-III reactivity (100% and 53%) against AF. There was elevated total IgE (100%, n = 29), a positive family history of asthma (63%), peripheral eosinophilia (100%) and a history of passage of brownish plugs (31%). Radiological findings suggested soft shadow with infiltration in 31% and fluctuating pneumonic shadows in 69% of cases. CT Thorax (n = 31) showed central bronchiectasis in 78% of theses patients. Based on the present data, the prevalence of ABPA in bronchial asthma patients is 16% (12% with central bronchiectasis and 4% only serologically positive). Therefore, patients should be investigated and diagnosed in an early phase of ABPA (ABPA-S) and should be treated to prevent permanent lung damage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11316037

Source DB:  PubMed          Journal:  Asian Pac J Allergy Immunol        ISSN: 0125-877X            Impact factor:   2.310


  8 in total

1.  Youngest Case of Allergic Broncho Pulmonary Aspergillosis in India: A Case Report from Arid Zone of India.

Authors:  Navgeet Mathur; Medha Mathur; Virendra Singh
Journal:  J Clin Diagn Res       Date:  2017-04-01

2.  Allergic bronchopulmonary aspergillosis: A review of 42 patients from a tertiary care center in India.

Authors:  R Prasad; R Garg; A D Shukla
Journal:  Lung India       Date:  2009-04

Review 3.  Burden and distinctive character of allergic bronchopulmonary aspergillosis in India.

Authors:  Ritesh Agarwal
Journal:  Mycopathologia       Date:  2014-06-20       Impact factor: 2.574

4.  Occurrence of allergic bronchopulmonary mycosis in patients with asthma: An Eastern India experience.

Authors:  Anirban Sarkar; Abhijit Mukherjee; Aloke Gopal Ghoshal; Somenath Kundu; Subhra Mitra
Journal:  Lung India       Date:  2010-10

5.  Allergic bronchopulmonary aspergillosis: A clinical review of 24 patients: Are we right in frequent serologic monitoring?

Authors:  Subramanian Natarajan; Poonam Subramanian
Journal:  Ann Thorac Med       Date:  2014-10       Impact factor: 2.219

Review 6.  Allergic bronchopulmonary aspergillosis.

Authors:  Ritesh Agarwal; Inderpaul S Sehgal; Sahajal Dhooria; Valliappan Muthu; Kuruswamy T Prasad; Amanjit Bal; Ashutosh N Aggarwal; Arunaloke Chakrabarti
Journal:  Indian J Med Res       Date:  2020-06       Impact factor: 2.375

7.  Diagnostic performance of various tests and criteria employed in allergic bronchopulmonary aspergillosis: a latent class analysis.

Authors:  Ritesh Agarwal; Dipesh Maskey; Ashutosh Nath Aggarwal; Biman Saikia; Mandeep Garg; Dheeraj Gupta; Arunaloke Chakrabarti
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

8.  Diagnosis of allergic bronchopulmonary aspergillosis in patients with persistent allergic asthma using three different diagnostic algorithms.

Authors:  Vida Mortezaee; Seyed Alireza Mahdaviani; Mihan Pourabdollah; Maryam Hassanzad; Maryam Sadat Mirenayat; Payam Mehrian; Naser Behnampour; Jamshid Yazdani Charati; Zahra Peirovi; Somayeh Sharifynia; Seyedmojtaba Seyedmousavi; Mohammad T Hedayati
Journal:  Mycoses       Date:  2020-12-08       Impact factor: 4.931

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.